8-K: Accuray Faces Nasdaq Delisting Threat Over Sub-$1 Share Price

Accuray Incorporated received a Nasdaq notice for failing to maintain a minimum $1 bid price, initiating a 180-day compliance period to avoid potential delisting.

Summary

• Accuray Incorporated received a notice from Nasdaq on February 2, 2026, indicating non-compliance with Listing Rule 5550(a)(2).
• The non-compliance is due to the company's common stock failing to maintain a minimum bid price of $1 per share for the last 30 consecutive business days.
• The notification does not immediately affect the listing, and Accuray's common stock will continue to trade on Nasdaq under the symbol ARAY.
• Nasdaq has granted a 180-calendar day compliance period, until August 3, 2026, for Accuray to regain compliance.
• To regain compliance, the common stock must maintain a closing bid price of at least $1.00 for a minimum of ten consecutive business days during this period.
• If compliance is not regained, the company may be eligible for an additional 180-day period by transferring to the Nasdaq Capital Market, provided it meets other listing standards and intends to cure the deficiency, potentially through a reverse stock split.
• Accuray is currently evaluating options and intends to timely regain compliance, though there is no assurance it will be successful.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a significantly negative development, as it highlights sustained underperformance in share price and introduces the material risk of delisting, which can severely impact investor confidence and liquidity.

Positives

• No immediate effect on the listing of the company's common stock, which continues to trade on Nasdaq.
• Nasdaq has provided a 180-calendar day compliance period, offering time to address the deficiency.

Negatives

• Accuray is not in compliance with Nasdaq Listing Rule 5550(a)(2) due to its common stock trading below the minimum $1 bid price for 30 consecutive business days.
• Failure to regain compliance within the specified period could lead to delisting from Nasdaq.

Risks

• There is no assurance that Accuray will be able to regain compliance with the Bid Price Rule within the 180-day period ending August 3, 2026.
• The company may not be eligible for a potential second 180-day compliance period, or Nasdaq may not grant a request for continued listing.
• Failure to regain compliance could result in the delisting of Accuray's common stock from Nasdaq.
• There is no assurance that the company will otherwise be in compliance with other Nasdaq continued listing requirements.

Future Outlook

Accuray intends to evaluate options and use all reasonable efforts to timely regain compliance with Nasdaq's Bid Price Rule. However, there is no assurance that the company will be able to regain compliance or meet other Nasdaq continued listing requirements.

Management Comments

• "The Company is currently evaluating options to regain compliance and intends to timely regain compliance with the Bid Price Rule."
• "Although the Company will use all reasonable efforts to achieve compliance with Rule 5550(a)(2), there can be no assurance that the Company will be able to regain compliance with the Bid Price Rule or will otherwise be in compliance with other Nasdaq continued listing requirements."

Industry Context

StockSavvy.ai notes that companies often face challenges maintaining minimum bid prices, especially in volatile markets or during periods of underperformance. Such notices are common and typically trigger a strategic review of options, including operational improvements, investor relations efforts, or, as a last resort, a reverse stock split to boost share price. This situation places Accuray under increased scrutiny regarding its market valuation and operational stability.

Comparison to Industry Standards

• This situation is not uncommon for smaller-cap companies or those experiencing prolonged periods of market underperformance.
• For example, other companies like [Example Company A] and [Example Company B] have faced similar Nasdaq bid price deficiencies in the past, often resolving them through a combination of improved financial performance, strategic announcements, or reverse stock splits.
• The 180-day compliance period is standard for Nasdaq-listed companies.

Stakeholder Impact

• Shareholders: Face increased risk of delisting, which could lead to reduced liquidity, lower share price, and potential loss of investment. Uncertainty regarding the company's ability to regain compliance may also impact investor confidence.
• Employees: While not directly mentioned, delisting concerns can indirectly affect employee morale and retention due to perceived company instability.

Next Steps

• Accuray must maintain a closing bid price of at least $1.00 for a minimum of ten consecutive business days during the compliance period.
• Accuray is evaluating options to regain compliance.
• If compliance is not regained by August 3, 2026, Accuray may apply for a second 180-day compliance period by transferring to the Nasdaq Capital Market, provided it meets other listing standards and intends to cure the deficiency (e.g., reverse stock split).
• If compliance is not achieved or eligibility criteria are not met, Nasdaq will provide notice that the company's securities will be subject to delisting.

Key Dates

Recommendation

The notice of non-compliance with Nasdaq's minimum bid price rule signals significant underlying issues with the company's market valuation and investor confidence. While there's a compliance period, the risk of delisting is material and could severely impact liquidity and share price. The lack of immediate clarity on how the company plans to regain compliance, beyond "evaluating options," adds to the uncertainty. A seasoned investor would likely view this as a strong signal to exit or reduce exposure due to the heightened risk profile and potential for further share price erosion, especially if a reverse stock split becomes necessary, which often has a negative perception.

Keywords

Accuray, ARAY, Nasdaq, Delisting, Bid Price Rule, Compliance, Stock Market, SEC Filing, Corporate Governance, Listing Standards